Popular topics to explore
DEEPAKFERT
Q4FY25 – Operating Revenue Rs. 2,667 Cr. 28% Growth YoY, Op. EBITDA Rs. 480 Cr. 10% Growth YoY, Op. EBITDA Margin 18% 299 bps Negative Growth YoY, Profit after tax (PAT) Rs. 278 Cr. 21% Growth YoY.
FY25 – Operating Revenue Rs. 10,274 Cr. 18% Growth YoY, Op. EBITDA Rs. 1925 Cr. 50% Growth YoY, Op. EBITDA Margin 19% 390 bps Growth YoY, Profit after tax (PAT) Rs. 945 Cr. 102% Growth YoY.
Mining Chemicals revenue grew by 10% YoY in FY25 and growth likely to continue into FY26, driven by increasing power demand and infrastructure investments.
Industrial Chemicals revenue was flat in FY25 and outlook is steady, Margins might face slight pressure due to weak market dynamics.
Crop Nutrition Business bulk sales grew by 55% YoY in FY25 and growth likely to continue into FY26, as above-normal monsoon is expected.
The company is nearing the end of a major CAPEX cycle, with deleveraging expected post-FY26.
The Board declared Final dividend of Rs. 10 per Equity Share.#WatchOutFor#StockInNews#FundamentalViews#TrendingSectors#EquityResearch
279 likes·54 comments

















